Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2001 | 06-2001 | 03-2001 | 12-2000 | 09-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,510 | 46,000 | 10,930 | 11,440 | 5,330 |
| Marketable Securities | 32,230 | 0 | 2,870 | 7,780 | 2,810 |
| Receivables | 3,280 | 2,720 | 2,470 | 1,760 | 2,990 |
| Inventories | 3,550 | 2,870 | 2,260 | 2,940 | 3,670 |
| Other current assets | 1,170 | 700 | 420 | 10 | 880 |
| TOTAL | $49,740 | $52,290 | $18,950 | $24,300 | $15,680 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 9,699 | N/A |
| Investments And Advances | 630 | 680 | 690 | 690 | 610 |
| Intangibles | 0 | 0 | 0 | 32,609 | 0 |
| Other Non-Current Assets | 29,690 | 30,660 | 31,630 | -9,708 | 33,590 |
| TOTAL | $30,320 | $31,340 | $32,320 | $33,290 | $34,200 |
| Total Assets | $95,890 | $96,510 | $60,680 | $67,300 | $59,190 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 150 | 150 | 140 | 140 | 470 |
| Accounts payable and accrued liabilities | 3,420 | 1,110 | 1,330 | 2,270 | 3,190 |
| Accrued Expenses | 2,920 | 2,750 | 2,010 | 1,660 | 2,290 |
| TOTAL | $6,500 | $4,900 | $5,010 | $6,500 | $8,650 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,690 | 25,720 | 1,310 | 1,340 | 1,360 |
| Other Non-Current Liabilities | 22,830 | 400 | 400 | 400 | 520 |
| TOTAL | $26,520 | $26,120 | $1,710 | $1,740 | $1,880 |
| Total Liabilities | $33,030 | $31,030 | $6,720 | $8,250 | $10,530 |
| Shareholders' Equity | |||||
| Common Shares | 460 | 440 | 420 | 320 | 250 |
| Retained earnings | -63,440 | -56,670 | -50,520 | -45,190 | -39,380 |
| Other shareholders' equity | 6,710 | 8,290 | 8,190 | 27,180 | 35,550 |
| TOTAL | $62,860 | $65,480 | $53,950 | $59,050 | $48,650 |
| Total Liabilities And Equity | $95,890 | $96,510 | $60,670 | $67,300 | $59,180 |